{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:32:39Z","timestamp":1767990759454,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1378\/chest.12-1310","type":"journal-article","created":{"date-parts":[[2012,12,5]],"date-time":"2012-12-05T18:07:44Z","timestamp":1354730864000},"page":"1553-1561","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Inhaled Corticosteroid Dose Response Using Domiciliary Exhaled Nitric Oxide in Persistent Asthma"],"prefix":"10.1016","volume":"142","author":[{"given":"William J.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip M.","family":"Short","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Lipworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1378\/chest.12-1310_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1183\/09031936.00138707","article-title":"Global strategy for asthma management and prevention: GINA executive summary","volume":"31","author":"Bateman","year":"2008","journal-title":"Eur Respir J"},{"issue":"suppl 4","key":"10.1378\/chest.12-1310_bib2","first-page":"1","article-title":"British Guideline on the management of asthma","volume":"63","year":"2008","journal-title":"Thorax"},{"issue":"suppl 5","key":"10.1378\/chest.12-1310_bib3","first-page":"S94","article-title":"Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis and management of asthma-summary report 2007","volume":"120","author":"National Asthma Education and Prevention Program","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1378\/chest.12-1310_bib4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1067\/mai.2002.122635","article-title":"Significant variability in response to inhaled corticosteroids for persistent asthma","volume":"109","author":"Szefler","year":"2002","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1378\/chest.12-1310_bib5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1183\/09031936.06.00077205","article-title":"Influence of body mass index on the response to asthma controller agents","volume":"27","author":"Peters-Golden","year":"2006","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1378\/chest.12-1310_bib6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.anai.2011.12.006","article-title":"Does body mass index influence responsiveness to inhaled corticosteroids in persistent asthma?","volume":"108","author":"Anderson","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1378\/chest.12-1310_bib7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1378\/chest.11-0392","article-title":"Fluticasone\/salmeterol combination confers benefits in people with asthma who smoke","volume":"141","author":"Clearie","year":"2012","journal-title":"Chest"},{"issue":"1","key":"10.1378\/chest.12-1310_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/ACI.0b013e3280118a32","article-title":"The reclassification of asthma based on subphenotypes","volume":"7","author":"Green","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"9171","key":"10.1378\/chest.12-1310_bib9","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0140-6736(99)01813-9","article-title":"Non-eosinophilic corticosteroid unresponsive asthma","volume":"353","author":"Pavord","year":"1999","journal-title":"Lancet"},{"issue":"4 Pt 1","key":"10.1378\/chest.12-1310_bib10","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1164\/ajrccm.159.4.9806052","article-title":"Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment","volume":"159","author":"Sont","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"9347","key":"10.1378\/chest.12-1310_bib11","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","article-title":"Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial","volume":"360","author":"Green","year":"2002","journal-title":"Lancet"},{"issue":"3","key":"10.1378\/chest.12-1310_bib12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1378\/chest.11-1748","article-title":"A randomized primary care trial of steroid titration against mannitol in persistent asthma: STAMINA trial","volume":"141","author":"Lipworth","year":"2012","journal-title":"Chest"},{"issue":"5","key":"10.1378\/chest.12-1310_bib13","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"21","key":"10.1378\/chest.12-1310_bib14","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1056\/NEJMoa043596","article-title":"Use of exhaled nitric oxide measurements to guide treatment in chronic asthma","volume":"352","author":"Smith","year":"2005","journal-title":"N Engl J Med"},{"issue":"9643","key":"10.1378\/chest.12-1310_bib15","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0140-6736(08)61448-8","article-title":"Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial","volume":"372","author":"Szefler","year":"2008","journal-title":"Lancet"},{"issue":"5","key":"10.1378\/chest.12-1310_bib16","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1378\/chest.130.5.1319","article-title":"Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample","volume":"130","author":"Olin","year":"2006","journal-title":"Chest"},{"issue":"6","key":"10.1378\/chest.12-1310_bib17","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.jaci.2006.03.018","article-title":"Daily home measurements of exhaled nitric oxide in asthmatic children during natural birch pollen exposure","volume":"117","author":"Vahlkvist","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1378\/chest.12-1310_bib18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1378\/chest.12-1310_bib19","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1034\/j.1398-9995.2003.00226.x","article-title":"Relationship between airway hyperresponsiveness to mannitol and adenosine monophosphate","volume":"58","author":"Currie","year":"2003","journal-title":"Allergy"},{"issue":"4","key":"10.1378\/chest.12-1310_bib20","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1378\/chest.12-1310_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1034\/j.1399-3003.1999.14a08.x","article-title":"Development and validation of the Mini Asthma Quality of Life Questionnaire","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1378\/chest.12-1310_bib22","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3109\/02770900903229677","article-title":"Serial lung function variability using four portable logging meters","volume":"46","author":"Moore","year":"2009","journal-title":"J Asthma"},{"issue":"5","key":"10.1378\/chest.12-1310_bib23","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1378\/chest.119.5.1322","article-title":"Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients","volume":"119","author":"Silkoff","year":"2001","journal-title":"Chest"},{"issue":"3","key":"10.1378\/chest.12-1310_bib24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1164\/rccm.200610-1427OC","article-title":"The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial","volume":"176","author":"Shaw","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1378\/chest.12-1310_bib25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1183\/09031936.02.00285302","article-title":"Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship","volume":"20","author":"Jones","year":"2002","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1378\/chest.12-1310_bib26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1164\/rccm.200411-1498OC","article-title":"Exhaled nitric oxide: a predictor of steroid response","volume":"172","author":"Smith","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1378\/chest.12-1310_bib27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1081-1206(10)60909-X","article-title":"A comparison of 2 extrafine hydrofluoroalkane-134a-beclomethasone formulations on methacholine hyperresponsiveness","volume":"96","author":"Fardon","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1378\/chest.12-1310_bib28","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1080\/02770900903015654","article-title":"Inflammatory subtypes in asthma are related to airway hyperresponsiveness to mannitol and exhaled NO","volume":"46","author":"Porsbjerg","year":"2009","journal-title":"J Asthma"},{"issue":"3","key":"10.1378\/chest.12-1310_bib29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1398-9995.2009.02187.x","article-title":"Steroid sparing effects of intranasal corticosteroids in asthma and allergic rhinitis","volume":"65","author":"Nair","year":"2010","journal-title":"Allergy"},{"issue":"6","key":"10.1378\/chest.12-1310_bib30","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/thorax.58.6.500","article-title":"Sustained reduction in bronchial hyperresponsiveness with inhaled fluticasone propionate within three days in mild asthma: time course after onset and cessation of treatment","volume":"58","author":"Sovij\u00e4rvi","year":"2003","journal-title":"Thorax"},{"issue":"1","key":"10.1378\/chest.12-1310_bib31","first-page":"16","article-title":"Clinical dose-response relationship of fluticasone propionate in adults with asthma","volume":"59","author":"Masoli","year":"2004","journal-title":"Thorax"},{"issue":"1","key":"10.1378\/chest.12-1310_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.0306-5251.2001.bjcp.1399.x","article-title":"Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate","volume":"52","author":"Fowler","year":"2001","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1378\/chest.12-1310_bib33","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1378\/chest.122.2.618","article-title":"Therapeutic ratio of hydrofluoroalkane and chlorofluorocarbon formulations of fluticasone propionate","volume":"122","author":"Fowler","year":"2002","journal-title":"Chest"},{"issue":"4","key":"10.1378\/chest.12-1310_bib34","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.rmed.2005.08.012","article-title":"Identifying \u2018well-controlled\u2019 and \u2018not well-controlled\u2019 asthma using the Asthma Control Questionnaire","volume":"100","author":"Juniper","year":"2006","journal-title":"Respir Med"},{"issue":"5","key":"10.1378\/chest.12-1310_bib35","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.rmed.2004.10.008","article-title":"Measurement properties and interpretation of three shortened versions of the asthma control questionnaire","volume":"99","author":"Juniper","year":"2005","journal-title":"Respir Med"},{"issue":"5","key":"10.1378\/chest.12-1310_bib36","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1183\/09031936.02.02402001","article-title":"Variability and lack of predictive ability of asthma end-points in clinical trials","volume":"20","author":"Zhang","year":"2002","journal-title":"Eur Respir J"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212606904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212606904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T22:56:47Z","timestamp":1762124207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369212606904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0012369212606904"],"URL":"https:\/\/doi.org\/10.1378\/chest.12-1310","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhaled Corticosteroid Dose Response Using Domiciliary Exhaled Nitric Oxide in Persistent Asthma","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.12-1310","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}